MYL News and Press, Mylan N.V. From 03/26/20

Citing delays associated with the COVID-19 pandemic, Mylan N.V. (NASDAQ: MYL ) and Pfizer (NYSE: PFE ) now expect the merger between Mylan and Upjohn to be finalized in H2 instead of next quarter. More news on: Mylan N.V., Pfizer Inc., Healthcare stocks news, Merger & acquisition new...

HERTFORDSHIRE, England and PITTSBURGH and NEW YORK , March 26, 2020 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that due to the unprecedented circumstances surrounding the COVID-19 pandemic, including associated delays in the regulatory review ...

In a note, RBC Capital Markets says the selloff in Mylan N.V. ( MYL -2.3% ), stoked by India's three-week nationwide lockdown amid the COVID-19 pandemic, is overdone. More news on: Mylan N.V., Healthcare stocks news, Stocks on the move, Read more ...

Corona Virus Crisis Addressing the elephant in the room, the market is in shambles. With high unemployment that is projected to skyrocket into 2Q 2020, there is some hope for pharmaceutical companies as their operations continue. Deemed essential, pharmaceutical companies like AbbVie ( ABBV ...

Aimed at increasing supply during the COVID-19 pandemic, Mylan N.V. ( MYL -3.9% ) has waived its exclusive U.S. distribution rights for a generic version of AbbVie's ( ABBV +2.8% ) HIV antiviral combo pill Kaletra (lopinavir/ritonavir). More news on: Mylan N.V., AbbVie Inc., Lannett ...

HERTFORDSHIRE, England and PITTSBURGH , March 25, 2020 /PRNewswire/ --  Mylan (NASDAQ: MYL) today announced that, in its ongoing effort to support patients and public health needs in the current unprecedented circumstances surrounding the COVID-19 pandemic, Mylan has voluntar...

The FDA is alerting the medical community and patients that Mylan's ( MYL -3.7% ) emergency allergic reaction med EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, could have delayed injection or be prevented from properly injecting due to: More new...

Mylan Resurrects Old Malaria Medication to Fight COVID-19 Mylan ( MYL ) reported that it has decided to restart the production of hydroxychloroquine sulfate tablets. The restart is to allow the use of these tablets as potential treatment of COVID-19. It is expected that the tablets will be...

With no antibodies built up in the population, no known cure, and no existing vaccine against COVID-19, some may fear that there's no hope for those suffering with the disease now or in the future. However, there have actually been green shoots of positive results from several existing anti-vira...

Despite what President Donald Trump said at a White House briefing on Thursday, the Food and Drug Administration (FDA) hasn't approved chloroquine and its less-potent-but-safer offspring, hydrochloroquine, to treat COVID-19 , the disease caused by the new coronavirus. "Normally the FDA would t...